Amerant Trust News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research Analysts’ downgrades for Tuesday, May 31st: Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable […]

Amerant Bancorp (NASDAQ:AMTB – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm currently has a $31.00 price target on the stock. Zacks Investment Research‘s price target indicates a potential upside of 12.40% from the company’s previous close. […]

Zacks Investment Research cut shares of Amerant Bancorp (NASDAQ:AMTB – Get Rating) from a buy rating to a hold rating in a research note published on Tuesday, Zacks.com reports. According to Zacks, “Amerant Bancorp Inc. is a bank holding company. It operates through its subsidiaries, Amerant Bank, N.A., Amerant Investments, Inc. and Amerant Trust, N.A. […]

Zacks Investment Research upgraded shares of Amerant Bancorp (NASDAQ:AMTB – Get Rating) from a hold rating to a buy rating in a research report released on Wednesday morning, Zacks.com reports. The firm currently has $36.00 target price on the stock. According to Zacks, “Amerant Bancorp Inc. is a bank holding company. It operates through its […]

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amerant Announces Approval of Class B Share Repurchase Program Amerant Bancorp Inc.March 10, 2021 GMT CORAL GABLES, Fla., March 10, 2021 (GLOBE NEWSWIRE) -- Amerant Bancorp Inc. (NASDAQ: AMTB and AMTBB) (the “Company” or “Amerant”) today announced that on March 10, 2021, the Company’s Board of Directors (the “Board”) authorized a new share repurchase program (the “Repurchase Program”) authorizing the Company to purchase, from time to time, up to an aggregate amount of $40 million o...